Skip to main content
Erschienen in: Clinical and Translational Oncology 5/2013

01.05.2013 | Research Article

Dose–volume histogram parameters for predicting radiation pneumonitis using receiver operating characteristic curve

verfasst von: Dongqing Wang, Jian Shi, Shaohua Liang, Shiyong Lu, Xiangjie Qi, Qiang Wang, Guojing Zheng, Sheng Wang, Kemin Zhang, Hongfu Liu

Erschienen in: Clinical and Translational Oncology | Ausgabe 5/2013

Einloggen, um Zugang zu erhalten

Abstract

Objective

To assess the predictability of dose–volume histogram (DVH) parameters for radiation pneumonitis (RP) using receiver operating characteristic (ROC) curve.

Methods

One hundred and thirty-five cases of locally advanced non-small cell lung cancer patients treated with three-dimensional radiotherapy and chemotherapy were analyzed retrospectively. The end point of follow-up was ≥2 grade RP defined according to the National Cancer Institute Common Terminology Criteria for Adverse Events, version 3.0. The ROC curve was used to explore the predictive sensitivity (SEN), specificity (SPE), positive predictive value (PPV), and negative predictive value (NPV) for potential DVH parameters associated with RP.

Results

Relative volumes of total lungs receiving ≥5 Gy (V 5), ≥10 Gy (V 10), ≥13 Gy (V 13), ≥20 Gy (V 20), and mean lung dose (MLD), were all correlated to the development of RP (p < 0.05), among which V 5 and V 20 were the most important factors (p = 0.045 and 0.037; OR = 3.166 and 3.030). However, collinearity was found between V 5 and V 20 (Spearman’s rho 0.771, p < 0.01). The area under the ROC curve was 0.643 and 0.648 for using V 5 and V 20 as predictors. If predictive cut-off values were established as follows: V 5 = 0.8 and V 20 = 0.3, the parameters could provide predictive SEN, SPE, PPV and NPV were 0.387 and 0.581, 0.882 and 0.701, 0.444 and 0.321, and 0.855 and 0.873, respectively.

Conclusions

V 5 and V 20 could act as predictors for RP; however, single DVH metrics did not appear to have high predictive power for RP.
Literatur
1.
Zurück zum Zitat Claude L, Pérol D, Ginestet C et al (2004) A prospective study on radiation pneumonitis following conformal radiation therapy in non-small-cell lung cancer: clinical and dosimetric factors analysis. Radiother Oncol 71:175–181PubMedCrossRef Claude L, Pérol D, Ginestet C et al (2004) A prospective study on radiation pneumonitis following conformal radiation therapy in non-small-cell lung cancer: clinical and dosimetric factors analysis. Radiother Oncol 71:175–181PubMedCrossRef
2.
Zurück zum Zitat Graham MV, Purdy JA, Emami B et al (1999) Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 45:323–329PubMedCrossRef Graham MV, Purdy JA, Emami B et al (1999) Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 45:323–329PubMedCrossRef
3.
Zurück zum Zitat Gopal R, Tucker SL, Komaki R et al (2003) The relationship between local dose and loss of function for irradiated lung. Int J Radiat Oncol Biol Phys 56:106–113PubMedCrossRef Gopal R, Tucker SL, Komaki R et al (2003) The relationship between local dose and loss of function for irradiated lung. Int J Radiat Oncol Biol Phys 56:106–113PubMedCrossRef
4.
Zurück zum Zitat Schallenkamp JM, Miller RC, Brinkmann DH et al (2007) Incidence of radiation pneumonitis after thoracic irradiation: dose-volume correlates. Int J Radiat Oncol Biol Phys 67:410–416PubMedCrossRef Schallenkamp JM, Miller RC, Brinkmann DH et al (2007) Incidence of radiation pneumonitis after thoracic irradiation: dose-volume correlates. Int J Radiat Oncol Biol Phys 67:410–416PubMedCrossRef
5.
Zurück zum Zitat Yorke ED, Jackson A, Rosenzweig KE et al (2005) Correlation of dosimetric factors and radiation pneumonitis for non-small-cell lung cancer patients in a recently completed dose escalation study. Int J Radiat Oncol Biol Phys 63:672–682PubMedCrossRef Yorke ED, Jackson A, Rosenzweig KE et al (2005) Correlation of dosimetric factors and radiation pneumonitis for non-small-cell lung cancer patients in a recently completed dose escalation study. Int J Radiat Oncol Biol Phys 63:672–682PubMedCrossRef
6.
Zurück zum Zitat Trotti A, Colevas AD, Setser A et al (2003) CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 13:176–181PubMedCrossRef Trotti A, Colevas AD, Setser A et al (2003) CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 13:176–181PubMedCrossRef
7.
Zurück zum Zitat Giroux Leprieur E, Fernandez D, Chatellier G et al (2012) Non-small cell lung cancer: risk factors of radiation pneumonitis. Cancer Radiother (Epub ahead of print) Giroux Leprieur E, Fernandez D, Chatellier G et al (2012) Non-small cell lung cancer: risk factors of radiation pneumonitis. Cancer Radiother (Epub ahead of print)
8.
Zurück zum Zitat Palma DA, Senan S, Tsujino K et al (2012) Predicting radiation pneumonitis after chemoradiation therapy for lung cancer: an international individual patient data meta-analysis. Int J Radiat Oncol Biol Phys (Epub ahead of print) Palma DA, Senan S, Tsujino K et al (2012) Predicting radiation pneumonitis after chemoradiation therapy for lung cancer: an international individual patient data meta-analysis. Int J Radiat Oncol Biol Phys (Epub ahead of print)
9.
Zurück zum Zitat Dang J, Li G, Lu X et al (2010) Analysis of related factors associated with radiation pneumonitis in patients with locally advanced non-small-cell lung cancer treated with three-dimensional conformal radiotherapy. J Cancer Res Clin Oncol 136:1169–1178PubMedCrossRef Dang J, Li G, Lu X et al (2010) Analysis of related factors associated with radiation pneumonitis in patients with locally advanced non-small-cell lung cancer treated with three-dimensional conformal radiotherapy. J Cancer Res Clin Oncol 136:1169–1178PubMedCrossRef
10.
Zurück zum Zitat Jin H, Tucker SL, Liu HH et al (2009) Dose-volume thresholds and smoking status for the risk of treatment-related pneumonitis in inoperable non-small cell lung cancer treated with definitive radiotherapy. Radiother Oncol 91:427–432PubMedCrossRef Jin H, Tucker SL, Liu HH et al (2009) Dose-volume thresholds and smoking status for the risk of treatment-related pneumonitis in inoperable non-small cell lung cancer treated with definitive radiotherapy. Radiother Oncol 91:427–432PubMedCrossRef
11.
Zurück zum Zitat Rodrigues G, Lock M, D’Souza D et al (2004) Prediction of radiation pneumonitis by dose-volume histogram parameters in lung cancer–a systematic review. Radiother Oncol 71:127–138PubMedCrossRef Rodrigues G, Lock M, D’Souza D et al (2004) Prediction of radiation pneumonitis by dose-volume histogram parameters in lung cancer–a systematic review. Radiother Oncol 71:127–138PubMedCrossRef
12.
Zurück zum Zitat Lind PA, Marks LB, Hollis D et al (2002) Receiver operating characteristic curves to assess predictors of radiation-induced symptomatic lung injury. Int J Radiat Oncol Biol Phys 54:340–347PubMedCrossRef Lind PA, Marks LB, Hollis D et al (2002) Receiver operating characteristic curves to assess predictors of radiation-induced symptomatic lung injury. Int J Radiat Oncol Biol Phys 54:340–347PubMedCrossRef
13.
Zurück zum Zitat De Jaeger K, Seppenwoolde Y, Kampinga HH et al (2004) Significance of plasma transforming growth factor-beta levels in radiotherapy for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 58:1378–1387PubMedCrossRef De Jaeger K, Seppenwoolde Y, Kampinga HH et al (2004) Significance of plasma transforming growth factor-beta levels in radiotherapy for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 58:1378–1387PubMedCrossRef
14.
Zurück zum Zitat Arpin D, Perol D, Blay JY et al (2005) Early variations of circulating interleukin-6 and interleukin-10 levels during thoracic radiotherapy are predictive for radiation pneumonitis. J Clin Oncol 23:8748–8756PubMedCrossRef Arpin D, Perol D, Blay JY et al (2005) Early variations of circulating interleukin-6 and interleukin-10 levels during thoracic radiotherapy are predictive for radiation pneumonitis. J Clin Oncol 23:8748–8756PubMedCrossRef
15.
Zurück zum Zitat Yuan X, Liao Z, Liu Z et al (2009) Single nucleotide polymorphism at re1982073:T869C of the TGFbeta1 gene is associated with the risk of radiation pneumonitis in patients with non-small-cell lung cancer treated with definitive radiotherapy. J Clin Oncol 27:3370–3378PubMedCrossRef Yuan X, Liao Z, Liu Z et al (2009) Single nucleotide polymorphism at re1982073:T869C of the TGFbeta1 gene is associated with the risk of radiation pneumonitis in patients with non-small-cell lung cancer treated with definitive radiotherapy. J Clin Oncol 27:3370–3378PubMedCrossRef
16.
Zurück zum Zitat Hildebrandt MA, Komaki R, Liao Z et al (2010) Genetic variants in inflammation-related genes are associated with radiation-induced toxicity following treatment for non-small cell lung cancer. PLoS ONE 5:e12402PubMedCrossRef Hildebrandt MA, Komaki R, Liao Z et al (2010) Genetic variants in inflammation-related genes are associated with radiation-induced toxicity following treatment for non-small cell lung cancer. PLoS ONE 5:e12402PubMedCrossRef
17.
Zurück zum Zitat Jenkins P, Watts J (2011) An improved model for predicting radiation pneumonitis incorporating clinical and dosimetric variables. Int J Radiat Oncol Biol Phys 80:1023–1029PubMedCrossRef Jenkins P, Watts J (2011) An improved model for predicting radiation pneumonitis incorporating clinical and dosimetric variables. Int J Radiat Oncol Biol Phys 80:1023–1029PubMedCrossRef
18.
Zurück zum Zitat Wang D, Sun J, Zhu J et al (2012) Functional dosimetric metrics for predicting radiation-induced lung injury in non-small cell lung cancer patients treated with chemoradiotherapy. Radiat Oncol 7:69PubMedCrossRef Wang D, Sun J, Zhu J et al (2012) Functional dosimetric metrics for predicting radiation-induced lung injury in non-small cell lung cancer patients treated with chemoradiotherapy. Radiat Oncol 7:69PubMedCrossRef
Metadaten
Titel
Dose–volume histogram parameters for predicting radiation pneumonitis using receiver operating characteristic curve
verfasst von
Dongqing Wang
Jian Shi
Shaohua Liang
Shiyong Lu
Xiangjie Qi
Qiang Wang
Guojing Zheng
Sheng Wang
Kemin Zhang
Hongfu Liu
Publikationsdatum
01.05.2013
Verlag
Springer Milan
Erschienen in
Clinical and Translational Oncology / Ausgabe 5/2013
Print ISSN: 1699-048X
Elektronische ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-012-0931-y

Weitere Artikel der Ausgabe 5/2013

Clinical and Translational Oncology 5/2013 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.